312638-96-3Relevant academic research and scientific papers
THIAZOLYL COMPOUNDS USEFUL AS KINASE INHIBITORS
-
, (2008/12/04)
The invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's disease
Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands
Bakshi, Raman K.,Hong, Qingmei,Tang, Rui,Kalyani, Rubana N.,MacNeil, Tanya,Weinberg, David H.,Van Der Ploeg, Lex H. T.,Patchett, Arthur A.,Nargund, Ravi P.
, p. 1130 - 1133 (2007/10/03)
Design and synthesis of potent MC4 selective agonists based on cyclohexylpiperidine derived cyclic urea, oxazolidinones, and sulfonamide based privileged structures are disclosed.
MELANOCORTIN RECEPTOR AGONISTS
-
Page/Page column 38, (2010/02/11)
The present invention relates a compound of formula 1, and pharmaceutically acceptable salt, hydrate, solvate, or isomer thereof effective as agonist of melanocortin receptor, and an agonistic composition of melanocortin receptor comprising the same as active ingredient.
Substituted piperidines as melanocortin-4 receptor agonists
-
Page column 51, (2010/02/05)
Certain novel substituted piperidine compounds are agonists of the human melanocortin receptor(s) and, in particular, are selective agonists of the human melanocortin-4 receptor (MC-4R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the activation of MC-4R, such as obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction. Also provided are methods of treating sexual dysfunction with a compound that is a selective agonist of MC-4R over any other human melanocortin receptor.
